Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP
AssigneeMonsanto Company
InventorsMark J. Rupar, William P. Donovan, Yuping Tan, Annette C. Slaney
Life of this patent
Estimating the term…
Loading patent…
AssigneeMonsanto Company
InventorsMark J. Rupar, William P. Donovan, Yuping Tan, Annette C. Slaney
Estimating the term…
Disclosed is a novel .delta.-endotoxin, designated CryET29, that exhibits insecticidal activity against siphonapteran insects, including larvae of the cat flea (Ctenocephalides felis), as well as against colcopteran insects, including the southern corn rootworm (Diabrotica undecimpunctata), western corn rootworm (D. virgifera), Colorado potato beetle (Leptinotarsa decemlineata), Japanese beetle (Popillia japonica), and red flour beetle (Tribolium castaneur). Also disclosed are nucleic acid segments encoding CryET29, recombinant vectors, host cells, and transgenic plants comprising a cryET29 DNA segment. Methods for making and using the disclosed protein and nucleic acid segments are disclosed as well as assays and diagnostic kits for detecting cryET29 and CryET29 sequences in vivo and in vitro.
An isolated and purified Bacillus thuringiensis CryET29 crystal protein comprising SEQ ID NO:2.
An isolated and purified CryFT29 crystal protein comprising SEQ ID NO:2 having insecticidal activity against the southern corn rootworrn, Diabrotica undecimpunctata howardi, the Colorado potato beetle, Leptinotarsa decemlineata, the western corn rootworm, Diabrotica virgifera virgifera, the Japanese beetle, Popillia japonica, the red flour beetle, Tribolium castaneum, or the cat flea, Ctenocephalides felis.
A composition comprising a CryET29 crystal protein comprising SEQ ID NO:2, wherein the composition is substantially free of intact cells.
A method of treating flea infestation of an animal, comprising administering to said animal a therapeutically-effective amount of a pharmaceutically-acceptable CryET29 composition, wherein said composition is substantially free of intact cells and comprises an isolated and purified CryET29 crystal protein comprising SEQ ID NO:2.
A biologically pure culture of Bacillus thuringiensis cells that produces a CryET29 crystal protein comprising SEQ ID NO:2.
A composition comprising a CryET29 crystal protein comprising SEQ ID NO:2 prepared by a process comprising the steps of:
A method of preparing a CryET29 crystal protein comprising:
Dependencies are inferred from the claim text.